STACY WILLIAMS: Open Payments
NPI 1952062994 · MARGATE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 18 payments from 12 companies in 2025. Trend: 2023 $487 · 2024 $699 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Astellas Pharma US Inc | 3 | $102 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| ABBVIE INC. | 2 | $49 |
| Stryker Corporation | 1 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: AIRSUPRA, Veozah, AUSTEDO XR, Kerendia, VARIAX, QULIPTA, REXULTI, Auvelity.
Industry payments across FL — which companies pay providers there.
